Kids with a rare bone cancer might live longer if prescribed a drug that blocks blood supply to tumors, researchers say. The drug pazopanib (Votrient) extended the lives of a small group of kids with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback